BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2847352)

  • 1. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation.
    Cariou R; Tobelem G; Bellucci S; Soria J; Soria C; Maclouf J; Caen J
    Thromb Haemost; 1988 Aug; 60(1):54-8. PubMed ID: 2847352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating lupus-type anticoagulant, a risk factor for thrombosis by inhibition of protein C activation].
    Cariou R; Tobelem G; Caen J
    C R Acad Sci III; 1986; 303(4):113-8. PubMed ID: 3019490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody (SZ-53) against thrombomodulin inhibits thrombin-mediated release of t-PA and PGI2 from endothelial cells.
    Zhou Q; Zhao Y; Li P; Bai X; Ruan C
    Nouv Rev Fr Hematol (1978); 1991; 33(4):281-6. PubMed ID: 1664094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.
    Tsakiris DA; Settas L; Makris PE; Marbet GA
    J Rheumatol; 1990 Jun; 17(6):785-9. PubMed ID: 2167370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis.
    Freyssinet JM; Wiesel ML; Gauchy J; Boneu B; Cazenave JP
    Thromb Haemost; 1986 Jun; 55(3):309-13. PubMed ID: 3018955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clot lysis mediated by cultured human microvascular endothelial cells.
    Speiser W; Anders E; Binder BR; Müller-Berghaus G
    Thromb Haemost; 1988 Dec; 60(3):463-7. PubMed ID: 3149047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the lupus anticoagulant on endothelial fibrinolytic activity in vitro.
    Francis RB; Neely S
    Thromb Haemost; 1989 Apr; 61(2):314-7. PubMed ID: 2501901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB; McGehee WG; Feinstein DI
    Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of activated protein C and thrombin with the plasminogen activator inhibitor released from human endothelial cells.
    de Fouw NJ; van Hinsbergh VW; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1987 Apr; 57(2):176-82. PubMed ID: 3496680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells.
    Maruyama Y; Maruyama I; Soejima Y
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1262-9. PubMed ID: 8147869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endothelial cells and vascular hemostasis].
    Levin EG; Hanano M
    Nihon Rinsho; 1992 Feb; 50(2):303-6. PubMed ID: 1319512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.
    de Fouw NJ; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1988 Oct; 60(2):328-33. PubMed ID: 2975409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The suppression of the coagulation of nonanticoagulated whole blood in vitro by human umbilical endothelial cells cultivated on microcarriers is not dependent on protein C activation.
    Kohler HP; Müller M; Bombeli T; Straub PW; Haeberli A
    Thromb Haemost; 1995 Apr; 73(4):719-24. PubMed ID: 7495085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG binding to endothelial cells in systemic lupus erythematosus.
    Le Roux G; Wautier MP; Guillevin L; Wautier JL
    Thromb Haemost; 1986 Oct; 56(2):144-6. PubMed ID: 2949388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B.
    Hosaka Y; Takahashi Y; Ishii H
    Thromb Haemost; 1998 Feb; 79(2):371-7. PubMed ID: 9493593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of antithrombogenicity in endothelium by hemodynamic forces].
    Kawai Y; Matsumoto Y; Ikeda Y; Watanabe K
    Rinsho Byori; 1997 Apr; 45(4):315-20. PubMed ID: 9136594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells exhibit differential chemokinetic and mitogenic responsiveness to alpha-thrombin.
    Wang HS; Li F; Runge MS; Chaikof EL
    J Surg Res; 1997 Mar; 68(2):139-44. PubMed ID: 9184672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.